REGENXBIO INC.
6.350 $ -5.93%|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.350 USD | -5.93% |
|
+1.68% | -55.90% |
|
REGENXBIO Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-20-2026 09:30 AM
May. 22 |
|
Sarepta's Elevidys Faces 'Little' Pressure After Regenxbio Data, Wedbush Says
May. 15
MT
|
| Capitalization | 328M 283M 258M 244M 454M 31.37B 461M 3.07B 1.2B 15.02B 1.23B 1.21B 52.24B | P/E ratio 2026 * |
-2.34x | P/E ratio 2027 * | -2.29x |
|---|---|---|---|---|---|
| Enterprise value | 325M 281M 256M 242M 450M 31.1B 457M 3.05B 1.19B 14.89B 1.22B 1.2B 51.78B | EV / Sales 2026 * |
1.38x | EV / Sales 2027 * | 1.39x |
| Free-Float |
92.22% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: REGENXBIO Inc.
| 1 day | -5.93% | ||
| 1 week | +1.68% | ||
| Current month | -29.21% | ||
| 1 month | -30.30% | ||
| 3 months | -21.99% | ||
| 6 months | -46.19% | ||
| Current year | -55.90% |
| 1 week | 5.46 |  | 6.88 |
| 1 month | 5.46 | | 11.36 |
| Current year | 5.46 | | 16.19 |
| 1 year | 5.46 | | 16.19 |
| 3 years | 5.04 | | 28.8 |
| 5 years | 5.04 | | 46.46 |
| 10 years | 5.04 | | 85.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Curran Simpson
CEO | Chief Executive Officer | 64 | 2024-06-30 |
Mitchell Chan
DFI | Director of Finance/CFO | 45 | 2024-09-15 |
Craig Malzahn
CTO | Chief Tech/Sci/R&D Officer | 53 | 2025-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Allan Fox
CHM | Chairman | 78 | 2020-06-30 |
Kenneth Mills
CHM | Chairman | 51 | 2024-06-30 |
| Director/Board Member | 73 | 2015-04-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.93% | +1.68% | -34.13% | -68.31% | 349M | |
| -0.74% | +0.98% | +34.34% | +81.51% | 50.88B | |
| -0.24% | +0.94% | +67.57% | +54.73% | 46.43B | |
| -3.00% | -8.11% | +60.92% | +445.94% | 23.74B | |
| +1.33% | +0.16% | -7.01% | -13.48% | 22.99B | |
| -0.37% | +0.25% | +32.47% | -22.37% | 17.34B | |
| +0.09% | +2.35% | +25.35% | -38.93% | 16.39B | |
| -2.83% | -5.82% | +32.65% | +210.11% | 14.11B | |
| -4.87% | -8.38% | -34.59% | +889.29% | 13.56B | |
| +4.54% | +9.06% | +40.80% | - | 13.5B | |
| Average | -1.20% | +0.57% | +21.84% | +170.94% | 21.93B | |
| Weighted average by Cap. | -0.64% | +0.18% | +35.02% | +150.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 236M 203M 185M 176M 326M 22.55B 331M 2.21B 862M 10.79B 886M 867M 37.55B | 272M 235M 214M 203M 376M 26.02B 382M 2.55B 995M 12.46B 1.02B 1B 43.33B |
| Net income | -171M -147M -134M -127M -236M -16.33B -240M -1.6B -624M -7.82B -641M -628M -27.19B | -188M -162M -148M -140M -260M -17.95B -264M -1.76B -686M -8.59B -705M -690M -29.89B |
| Net Debt | -2.87M -2.47M -2.25M -2.13M -3.96M -274M -4.02M -26.83M -10.47M -131M -10.76M -10.53M -456M | 49.81M 42.94M 39.13M 37.06M 68.82M 4.76B 69.87M 466M 182M 2.28B 187M 183M 7.93B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-22 | 6.350 $ | -5.93% | 1.57M |
| 26-05-21 | 6.750 $ | +13.07% | 2.97M |
| 26-05-20 | 5.970 $ | +5.48% | 2.25M |
| 26-05-19 | 5.660 $ | +0.18% | 1.78M |
| 26-05-18 | 5.650 $ | -1.22% | 2.61M |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RGNX Stock
Select your edition
All financial news and data tailored to specific country editions
